Who decides if it’s treatment or a medical experiment?

Current worrisome trends U.S. government and academic bioethicists and institutional ethics review boards (IRB) have expunged the explicit honest terminology of the Nuremberg Code: “experiment” has been replaced by the innocuous term “study”; “human subject” is being replaced by “participant”; and the . . . Continue reading →

A Recent Deadly Drug Experiment – BIA 10-2474 – Rennes, France

Stakeholders in the Medical research enterprise, in the European Union and in the U.S., claim that clinical trials conducted on human subjects adhere to strict safety standards. “One of the things that sets clinical trials apart from other scientific experiments is the . . . Continue reading →

Medical Research Stakeholders Seek to Overturn Informed Consent Protections

Part 2 of 4. The Medical Research Enterprise: a confluence of self-interest groups: government officials, academic researchers. . . . Continue reading →